The sequencing of genes is the gold standard for identifying mutations.

Scientists also are focusing on identifying disease-associated mutations (changes in genes).

Some studies have identified mutations that occur, as these strains are derived from normal bacteria.

In 2012 BRC researchers worked on the team which identified genetic mutations associated with dystonia.

The G progeny can be screened to identify dominant mutations.

Predictive testing can identify mutations that increase a person's risk of developing disorders with a genetic basis, such as certain types of cancer.

The aim of this technique is to identify mutations that produce a certain phenotype.

Thus, identifying and targeting specific mutations which have occurred in an individual patient may lead to increased efficacy of cancer therapy.

Such screening would identify novel as well as known mutations.

Castle had also had difficulty identifying mutations in Drosophila, which were tiny.